Cancer-associated Thrombosis in Vietnam: Literature Review and Expert Perspectives

Author:

Hoang Sy Van12,Ho Tri Huynh Quang3,Dang Thinh Huy Quoc4,Nguyen Hien Thanh5,Pham Phuong Cam6,Do Tu Anh7,Bui Hai Hoang8,Nguyen Hai Tuan89,Vuong Hao Dinh Thy10,Dang Duc Quy1,Than The Ha Ngoc2,Nguyen Hai Hoang11,Phan Thuan Tan4,Dinh Huong Thi Thu8

Affiliation:

1. Department of Cardiovascular, Cho Ray Hospital, Hanoi, Vietnam

2. University of Medicine and Pharmacy at HCMC, Hanoi, Vietnam

3. Surgical Intensive Care Unit, Heart Institute, Hanoi, Vietnam

4. Ho Chi Minh City Oncology Hospital, Hanoi, Vietnam

5. University Medical Center, Ho Chi Minh City, Hanoi, Vietnam

6. Nuclear Medicine and Oncology Center, Bach Mai Hospital, Hanoi, Vietnam

7. K Hospital, Hanoi, Vietnam

8. Hanoi Medical University, Hanoi, Vietnam

9. Vietnam Heart Institute, Bach Mai Hospital, Hanoi, Vietnam

10. Department of Chemotherapy, Cho Ray Hospital, Hanoi, Vietnam

11. Gia Dinh Hospital, Ho Chi Minh City, Hanoi, Vietnam

Abstract

Cancer-associated thrombosis (CAT) is a substantial burden and an emerging topic of great interest in Vietnam. The management of CAT is complex, with several challenges, including a high risk of bleeding and thrombosis, treatment burden, and low treatment motivation due to the short life expectancy of patients. Another challenge in CAT management is the low awareness among local physicians regarding CAT. The introduction of direct oral anticoagulants, which offer a better risk–benefit profile compared to conventional anticoagulation, has brought about a revolution in CAT management. To address these challenges, a group of 14 experts, including cardiologists and oncologists, convened in January 2023 to discuss and provide comprehensive information on CAT management in Vietnam, along with recommendations to optimize clinical outcomes. This review will encompass the available evidence in the medical literature and the expert opinions derived from the meeting.

Publisher

Medknow

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3